期刊文献+

436例宫颈癌前病变及宫颈癌临床分析 被引量:4

下载PDF
导出
摘要 目的对宫颈癌前病变及宫颈癌的发病情况进行分析。方法对平江县妇幼保健院2008年1月至2011年6月4250例体检及妇科门诊患者采用新柏氏液基薄层细胞学技术进行子宫颈癌前病变及宫颈癌筛查,诊断结果表现为非典型柱状细胞(AGCUS)或不典型鳞状细胞性质(ASCUS)为阳性病例,并按年龄进行分组分析。结果阳性病例436例,以30~40岁年龄组的宫颈癌前病变及宫颈癌发病率最高,其次为20~30岁组,与其他年龄组相比较,差异明显,具有统计学意义P<0.05。结论 30~40岁是妇女宫颈癌前病变及宫颈癌的多发年龄段,且发病呈年轻化趋势,建议20~40岁年龄段有性经历的妇女应定期做宫颈癌的筛查。
作者 林明
出处 《中国医药指南》 2011年第30期72-73,共2页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献47

  • 1[2]Mitchell MF,Schottenfeld D,Tortolero-Luna G,et al. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis.Obstet Gynecol, 1998,91:626
  • 2[3]Raymond HK,Ervin A,Joseph I,et al. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity ,and cost-effectiveness. Am J Obstet Gynecol, 1997,177:930
  • 3[4]Reid R, Stanhope CR, Herschman BR, et al. Genital warts and cervical cancer Ⅳ-a colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol,1984,149 (8): 815
  • 4Karube A, Sasaki M, Tanaka H, et al. Human papillomavirus typel6 infection and the early onset of cervical cancer [ J ].Bioche Biophys Res Commun, 2004, 323 ( 2 ) :621-624.
  • 5Ault KA,Giuliano AR, Edwards RP,et al. A phase Ⅱ study to evaluate a human papillomavirus (HPV) type 18 LI VLP vaccine[ J ]. Vaccine, 2004, 22 (23-24) :3004-3007.
  • 6Matthews-Greer J, Rivette D, Reyes R,et al. Human papillomavirus detection : verification with cervical cytology [ J ]. Clin Lab Sci, 2004, 17( 1 ) :8-11.
  • 7Cox JT. Management of women with cervical cancer precursor lesions[ J]. Obstet Gynecol Clin North Am, 2002, 29 (4):787-816.
  • 8Nayar R, Tabbara SO. Atypical squamous cells:update on current comept[J]. Clin Lab Med,2003,23(3) :605-632.
  • 9Anderssons S, Rylander E, Larsson B,et al. The role of human papillomavirus in cervical carcinoma carcinogenesis [ J ]. Eur J Carcer, 2001,37(2) :246-250.
  • 10Wadler S,Levy D,Frederickson HL, A phase Ⅱ trial of IL-12 in patients with advanced cervical cancer: clinical and immunologic correlates, Eastern Cooperative Oncology Group study E1E96 [J]. Gynecol Oncol, 2004, 92(3) :957-964.

共引文献274

同被引文献26

引证文献4

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部